bendazac

Also known as bendazolic acid, EINECS 243-569-2, UNII-G4AG71204O, BRN 0893958

Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.

Research

111 papers

Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts.Drugs · 1990
Potential Application of Bendazac L-Lysine for Controlling Myopia Progression, as Demonstrated in Two Experimental Guinea Pig Myopia Models.Investigative ophthalmology & visual science · 2025
Allergic contact dermatitis due to bendazac and alclometasone dipropionate.Contact dermatitis · 1999
Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency.European journal of clinical pharmacology · 1987
Bendazac lysine in selected types of human senile cataract. A long-term double-masked placebo-controlled clinical trial with multilinear densitometric image analysis of Scheimpflug photographs.Ophthalmic research · 1989

via PubMed

Article

3 sections

Contents

Synthesis
See also
References

Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.

==Synthesis== Principal action is inhibition of protein denaturation. class=skin-invert-image|thumb|center|700px|Bendazac synthesis: ; G. Palazzo, (1967, 1969 both to Francesco Angelini). Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).